EWM
ABMD

Evercore Wealth Management’s Abiomed Inc ABMD Stock Holding History

Evercore Wealth Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-133
Closed -$17K – 1109
2016
Q3 		$17K Hold
133
– – ﹤0.01% 802
2016
Q2 		$15K Hold
133
– – ﹤0.01% 802
2016
Q1 		$13K Hold
133
– – ﹤0.01% 780
2015
Q4 		$12K Buy
+133
New +$11.3K ﹤0.01% 837

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
1832 Asset Management
1832 Asset Management Toronto, Ontario, Canada $109B AUM 35.56% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Evercore Wealth Management's ABMD Position: Q4 2016 in Review

Evercore Wealth Management sold out of Abiomed Inc (ABMD) in Q4 2016, closing a stake of 133 shares — an estimated $17K sold.

Evercore Wealth Management first reported a position in ABMD in Q4 2015 and held it in 4 quarters. The position peaked at $17K in Q3 2016. 297 funds tracked by Wall St. Rank hold ABMD as of Q4 2016.

  • Evercore Wealth Management reported no remaining Abiomed Inc position as of Q4 2016 after selling out during the quarter.
  • Evercore Wealth Management sold 133 Abiomed Inc shares in Q4 2016, an estimated $17K.
  • Evercore Wealth Management first reported a position in Abiomed Inc in Q4 2015 and held it in 4 quarters.
  • Evercore Wealth Management's Abiomed Inc position peaked at $17K in Q3 2016.
  • 297 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2016.

Based on Evercore Wealth Management's 13F filing for Q4 2016, filed 8 Feb 2017.